Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

NovoCure Limited - Ordinary Shares (NQ:NVCR)

13.44 UNCHANGED

Streaming Delayed Price Updated: 1:00 PM EST, Dec 24, 2025 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	0
Open	-
Bid (Size)	13.23 (100)
Ask (Size)	13.54 (100)
Prev. Close	13.44
Today's Range	13.44 - 13.44
52wk Range	10.70 - 32.05
Shares Outstanding	103,647,871
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

NovoCure (NVCR) Q4 2024 Earnings Call Transcript ↗

December 23, 2025

NovoCure (NVCR) Q4 2024 Earnings Call Transcript

Via The Motley Fool

NovoCure (NVCR) Q3 2024 Earnings Call Transcript ↗

December 23, 2025

NovoCure (NVCR) Q3 2024 Earnings Call Transcript

Via The Motley Fool

Performance

YTD	-55.2%	-55.2%
1 Month	+7.3%	+7.3%
3 Month	+4.7%	+4.7%
6 Month	-22.4%	-22.4%
1 Year	-56.6%	-56.6%

More News

Novocure (NVCR) Q2 2025 Earnings Call Transcript ↗

December 23, 2025

Via The Motley Fool

Novocure to Present at 44th Annual J.P. Morgan Healthcare Conference

December 22, 2025

From Novocure

Via Business Wire

Earnings Scheduled For October 30, 2025 ↗

October 30, 2025

Via Benzinga

Novocure Appoints Company President Frank Leonard as Chief Executive Officer

December 01, 2025

From Novocure

Via Business Wire

NovoCure (NVCR) Q3 2025 Earnings Call Transcript ↗

November 27, 2025

Via The Motley Fool

Novocure to Participate in 37th Annual Piper Sandler Healthcare Conference

November 26, 2025

From Novocure

Via Business Wire

2 Healthcare Stocks for Individual Investors With a 40-Year Time Horizon ↗

November 12, 2025

Via The Motley Fool

Novocure to Participate in 2025 Jefferies Global Healthcare Conference

November 12, 2025

From Novocure

Via Business Wire

Novocure (NASDAQ:NVCR) Q3 2025 Earnings: Revenue Beat and Narrower Loss Drive Shares Higher ↗

October 30, 2025

Via Chartmill

Novocure Reports Third Quarter 2025 Financial Results

October 30, 2025

From Novocure

Via Business Wire

Novocure to Present New Research for Tumor Treating Fields (TTFields) Therapy at European Association of Neuro-Oncology (EANO) Meeting and the European Society for Medical Oncology (ESMO) Congress

October 15, 2025

From Novocure

Via Business Wire

Novocure to Report Third Quarter 2025 Financial Results

October 01, 2025

From Novocure

Via Business Wire

Novocure to Present Final Results from the Pivotal Phase 3 METIS Trial of its Tumor Treating Fields (TTFields) Therapy for Brain Metastases from Non-Small Cell Lung Cancer at 2025 ASTRO Annual Meeting

September 29, 2025

From Novocure

Via Business Wire

Novocure’s Optune Lua® Receives Approval in Japan for the Treatment of Unresectable Advanced/Recurrent Non-Small Cell Lung Cancer (NSCLC)

September 15, 2025

From Novocure

Via Business Wire

2 Beaten-Down Stocks That Could Rocket 142% to 222% Higher, According to Wall Street Analysts ↗

August 29, 2025

Via The Motley Fool

Novocure Announces Upcoming Investor Events

August 28, 2025

From Novocure

Via Business Wire

Novocure Announces Coverage of Tumor Treating Fields (TTFields) Therapy for Patients with Newly Diagnosed Glioblastoma in Spain

August 25, 2025

From Novocure

Via Business Wire

Novocure Submits Premarket Approval Application to FDA for Tumor Treating Fields Therapy in Locally Advanced Pancreatic Cancer

August 20, 2025

From Novocure

Via Business Wire

Top 3 Health Care Stocks That May Explode In July ↗

July 28, 2025

Via Benzinga

NovoCure Q2 Revenue Jumps 6 Percent ↗

July 24, 2025

Via The Motley Fool

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

July 24, 2025

Via Benzinga

Novocure: Steady Ahead of Key Milestones ↗

July 24, 2025

Via The Motley Fool

Novocure Reports Second Quarter 2025 Financial Results

July 24, 2025

From Novocure

Via Business Wire

Frequently Asked Questions

Is NovoCure Limited - Ordinary Shares publicly traded?

Yes, NovoCure Limited - Ordinary Shares is publicly traded.

What exchange does NovoCure Limited - Ordinary Shares trade on?

NovoCure Limited - Ordinary Shares trades on the Nasdaq Stock Market

What is the ticker symbol for NovoCure Limited - Ordinary Shares?

The ticker symbol for NovoCure Limited - Ordinary Shares is NVCR on the Nasdaq Stock Market

What is the current price of NovoCure Limited - Ordinary Shares?

The current price of NovoCure Limited - Ordinary Shares is 13.44

When was NovoCure Limited - Ordinary Shares last traded?

The last trade of NovoCure Limited - Ordinary Shares was at 12/24/25 01:00 PM ET

What is the market capitalization of NovoCure Limited - Ordinary Shares?

The market capitalization of NovoCure Limited - Ordinary Shares is 1.39B

How many shares of NovoCure Limited - Ordinary Shares are outstanding?

NovoCure Limited - Ordinary Shares has 1B shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.